![Catalyst Pharmaceuticals Inc](/common/images/company/N_CPRX.png)
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of p... Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome. Show more
CORAL GABLES, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc.ย ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on...
CORAL GABLES, Fla., July 22, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc.ย ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.7 | 4.16418798334 | 16.81 | 17.99 | 16.62 | 718546 | 17.11474095 | CS |
4 | 2.46 | 16.3455149502 | 15.05 | 17.99 | 14.75 | 791749 | 16.13221919 | CS |
12 | 2.38 | 15.7303370787 | 15.13 | 17.99 | 14.47 | 1081692 | 15.81631756 | CS |
26 | 2.45 | 16.2682602922 | 15.06 | 17.99 | 13.1161 | 1205231 | 15.47650777 | CS |
52 | 3.88 | 28.466617755 | 13.63 | 17.99 | 11.55 | 1273014 | 14.60743609 | CS |
156 | 11.96 | 215.495495495 | 5.55 | 22.11 | 4.81 | 1608978 | 13.01939351 | CS |
260 | 13.18 | 304.387990762 | 4.33 | 22.11 | 2.55 | 1708275 | 9.21127443 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.